Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 329 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Completed

A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer

NCT00179686

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Birmingham Cancer Center Birmingham, Alabama, United States
  • Rush Cancer Institute Chicago, Illinois, United States
  • University of Chicago Chicago, Illinois, United States
  • Cancer and Blood Institute Metairie, Louisiana, United States
View Trial Details
Active, Not Recruiting

Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)

NCT04656652

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • St. Joseph Heritage Healthcare Anaheim, California, United States
  • The Oncology Institute of Hope and Innovation Glendale, California, United States
  • University of California San Diego La Jolla, California, United States
View all 209 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Savolitinib Plus Osimertinib vs Savolitinib Plus Placebo in Patients With EGFRm+ and MET Amplified Advanced NSCLC

NCT04606771

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +15 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Sacramento, California, United States
  • Research Site Ciudad de Buenos Aires, Argentina
  • Research Site Delhi, India
View all 21 locations
View Trial Details
Active, Not Recruiting

A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations

NCT06644768

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of California San Diego (Ucsd)-Moores Cancer Center La Jolla, California, United States
  • California Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Mayo Clinic Hospital Jacksonville, Florida, United States
View all 35 locations
View Trial Details
Active, Not Recruiting

Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations

NCT05256290

Conditions
Advanced Lung Carcinoma, Advanced Non-Small Cell Squamous Lung Cancer, Brain Diseases, +23 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • City of Hope Huntington Beach Huntington Beach, California, United States
  • City of Hope Orange County Lennar Foundation Cancer Center Irvine, California, United States
View all 25 locations
View Trial Details
Active, Not Recruiting

A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84)

NCT06698042

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Providence Medical Foundation ( Site 0117) Fullerton, California, United States
  • Illinois Cancer Care ( Site 0101) Peoria, Illinois, United States
  • Montefiore Medical Center ( Site 0104) The Bronx, New York, United States
  • University of Cincinnati Medical Center ( Site 0112) Cincinnati, Ohio, United States
View all 67 locations
View Trial Details
Active, Not Recruiting

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

NCT06607185

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
View all 45 locations
View Trial Details

Related conditions